Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 and up

Early Pleural Irrigation with Saline vs Standard Care for Complicated Pleural Infections

Official title: Randomized Controlled Trial Comparing an Early Pleural Irrigation Strategy With Saline to the Standard of Care for the Management of Complicated Pleural Infections.

Run by Centre Hospitalier Universitaire, Amiens · NCT07666464 · Data updated 2026-11-12

This trial tests whether irrigating the pleural space with saline soon after drainage is better than standard care for adults with complicated pleural infections.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment244 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens, Picardie)
StatusRecruiting
StartedMay 13, 2026
Main results expectedMay 2029
Study endsAugust 2029
Registry record updatedJuly 1, 2026
Trial IDNCT07666464 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with complicated pleural infection requiring thoracic drainage and meeting specific imaging and laboratory criteria.

Probably not a fit

Patients without a response to drainage or those not fitting the infection criteria might not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 3 interventional study compares an early pleural saline irrigation strategy to standard care in adults with complicated pleural infections. The primary goal is to see if irrigation reduces treatment failure within 30 days, defined as death, need for thoracic surgery, or requirement for additional intrapleural enzyme therapy. Participants will have confirmed pleural infection with loculated effusion and are undergoing thoracic drainage. The trial will be conducted at multiple French centers and follows current guidelines that consider intrapleural enzyme therapy as rescue therapy. Outcomes will inform whether early irrigation can be a safer or more effective alternative.

Why it matters

Potential benefit: If successful, patients may experience fewer treatment failures and potentially quicker recovery.

How similar studies have gone: Previous small, single-center randomized data suggested potential benefit; this Phase 3 trial aims to provide more robust evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (≥18 years old) capable of fully understanding the study;
* Complicated pleural infection (macroscopically purulent fluid, positive for bacteria on Gram's staining, positive on culture for bacterial infection, loculated effusion, pH \<7.2, great abundance) leading to thoracic drainage;
* Initial ultrasound evaluation to estimate pleural fluid abundance and detect fibrinous septation;
* Social security affiliation
* Written informed consent
* Highly effective contraceptive methods for women of childbearing age include: Combined hormonal contraception (estrogen and progestogen) associated with inhibition of ovulation (oral, intravaginal, transdermal); progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, implantable); intrauterine device; hormone- releasing intrauterine system; bilateral occlusion of the Fallopian tubes; vasectomized partner; sexual abstinence

Exclusion Criteria:

* Tuberculous pleural effusions;
* Previous treatment with intrapleural fibrinolytic agents (urokinase, streptokinase, alteplase, or DNase) or intrapleural saline lavage;
* Previous thoracic surgery for pleural infection;
* Contraindications to auxiliary treatments, to fibrinolysis or surgery as well as to procedures such as drainage and lavage;
* Pregnancy or lactation;
* Expected survival of less than 3 months;
* Thoracic drainage since more than 24h;
* Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision);
* Inability to give informed written consent;
* Participation in another clinical trial;
* Patient being a relative of the investigator or any member of the team directly involved in the study, including assistant physicians, pharmacists, nurses, and coordinators

Where it's running

  • CHU Amiens Picardie
    Amiens, Picardie, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.